Splenic Primary Solid Tumors

Background The present study aims to present a case series of patients who underwent splenectomy for splenic primary solid tumors without preoperative histopathologic diagnosis. Methods From 2013 to 2019, 12 patients underwent splenectomy for solid primary splenic tumors at 3 different academic medi...

Full description

Saved in:
Bibliographic Details
Published in:The American surgeon 2021-02, Vol.87 (2), p.316-320
Main Authors: Gonzalez-Urquijo, Mauricio, Rodarte-Shade, Mario, Gil-Galindo, Gerardo
Format: Article
Language:English
Subjects:
Abdomen
Asymptomatic
Biopsy
Blood
Cancer
Complications
Diagnosis
Electronic health records
Electronic medical records
Health care facilities
Hospitals
Hypertension
Hypothyroidism
Laparoscopy
Lymphangioma
Lymphoma
Magnetic resonance imaging
Morbidity
Neoplasia
Patients
Rheumatoid arthritis
Solid tumors
Spleen
Splenectomy
Surgery
Surgical outcomes
Tumors
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The present study aims to present a case series of patients who underwent splenectomy for splenic primary solid tumors without preoperative histopathologic diagnosis. Methods From 2013 to 2019, 12 patients underwent splenectomy for solid primary splenic tumors at 3 different academic medical centers. All electronic medical records were retrospectively reviewed. Results Seven (58.3%) patients were women, and 5 (41.6%) were male. The median age was 48 years (range: 25-72 years). In 8 (66.6%) patients, a conventional approach was performed. In 2 (16.6%), a hand-assisted laparoscopic surgery procedure was completed, and in other 2 (16.6%) patients, a laparoscopic approach was auspiciously achieved. Median operative time was 135 minutes (range: 60-210 minutes), and median blood loss was 500 mL (range: 200-1500 mL). Procedure-related morbidity was found in 2 (16.6%) patients, and the mortality rate was 0%. The final histopathologic diagnosis was lymphoma in 5 (41.6%) patients, lymphangioma in 3 (25%) patients, hamartoma in 2 (16.6%) patients, angiosarcoma, and sclerosing angiomatoid nodular transformation (SANT) in 1 (8.3%) case each. Conclusion Splenectomy should be the treatment of choice when encountering a primary splenic tumor without the need for preoperative fine-needle aspiration biopsy, avoiding the complications this technique entails.
ISSN:0003-1348
1555-9823
DOI:10.1177/0003134820951480